CDK inhibitors in cancer therapy, an overview of recent development.
- Journal
- PubMed
In The Last Decade
doi.org/w75751287 →Countries where authors are citing CDK inhibitors in cancer therapy, an overview of recent development.
This map shows the geographic impact of CDK inhibitors in cancer therapy, an overview of recent development.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CDK inhibitors in cancer therapy, an overview of recent development. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CDK inhibitors in cancer therapy, an overview of recent development. more than expected).
Fields of papers citing CDK inhibitors in cancer therapy, an overview of recent development.
This network shows the impact of CDK inhibitors in cancer therapy, an overview of recent development.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the CDK inhibitors in cancer therapy, an overview of recent development..
About CDK inhibitors in cancer therapy, an overview of recent development.
This paper, published in 2021, received 219 indexed citations . Written by Lingxian Zhang, Ruoxuan Hei, Xiao Li, Xuan Wu, Qiping Zheng and Cheguo Cai covering the research area of Oncology, Pulmonary and Respiratory Medicine and Genetics. It is primarily cited by scholars working on Oncology (113 citations), Molecular Biology (107 citations) and Pulmonary and Respiratory Medicine (74 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w75751287.